Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $6.4800 (-6.76%) ($6.4550 - $6.4800) on Thu. Mar. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.06% (three month average) | RSI | 45 | Latest Price | $6.4800(-6.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.8% a day on average for past five trading days. | Weekly Trend | IOVA declines -1.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(49%) IBB(36%) IWC(28%) ACES(27%) ARKG(26%) | Factors Impacting IOVA price | IOVA will decline at least -2.03% in a week (0% probabilities). BND(-13%) XLP(-11%) VIXM(-11%) UUP(-9%) USO(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.03% (StdDev 4.06%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.29(-80.09%) | Resistance Level | $7.16 | 5 Day Moving Average | $7(-7.43%) | 10 Day Moving Average | $7.08(-8.47%) | 20 Day Moving Average | $7.16(-9.5%) | To recent high | -21.4% | To recent low | 15.5% | Market Cap | $949m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |